GLPG4716

Galapagos NV · Phase 1 active Small molecule

At a glance

Generic name	GLPG4716
Sponsor	Galapagos NV
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects (PHASE1)
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GLPG4716 CI brief — competitive landscape report
GLPG4716 updates RSS · CI watch RSS
Galapagos NV portfolio CI